Business
Assertio Provides Educational Grant for New Lennox-Gastaut Syndrome (LGS) Foundation Treatments Kits
SYMPAZAN (clobazam) oral CIV film from Assertio is used for the adjunctive treatment of seizures associated with LGS in patients two years of age and older
About this update from Assertio Holdings, Inc.
[{"type":"text","content":"SYMPAZAN (clobazam) oral CIV film from Assertio is used for the adjunctive treatment of seizures associated with LGS in patients two years of age and older Oral film delivery from SYMPAZAN® delivers clobazam to LGS patients with no crushing, no mixing, no prep work LAKE FOREST, Ill., April 24, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company, today announced that it is providing educational grant funding for the Lennox-Gastaut Syndrome (LGS) Foundation’s new About LGS Treatments Kits for families coping with LGS. Assertio markets SYMPAZAN® (clobazam) oral film CIV, approved by the U.S. Food and Drug Administration (FDA) for the adjunctive treatment of seizures associated with LGS in patients aged two years of age or older. Assertio announced in December that it provided a $100,000 educational grant to the LGS Foundation. “Assertio is proud to support the LGS community,” said Dan Peisert, President and Chief Executive Officer of Assertio. “Our focus is on working with the LGS Foundation to help raise awareness of LGS and to support development of educational materials that can benefit their community.” Tracy Dixon-Salazar, Ph.D, Executive Director of the LGS Foundation, said the kits will include information about medications to treat seizures associated with LGS, diet therapy, neuromodulatory treatments, epilepsy surgery, and much more. “I wish I had a kit like this when my daughter was first diagnosed with LGS over two decades ago,” said Dr. Dixon-Salazar. “Our community has told us that they need more information to help them understand their options for treatment of seizures in LGS. This kit will help do just that.” Dr. Dixon-Salazar said the Treatment Kits will be provided starting today to any family requesting one. Families impacted by Lennox-Gastaut Syndrome can request an About LGS Treatments Kit on the LGS Foundation’s website. About LGS FoundationThe Lennox-Gastaut Syndrome (LGS) Foundation is a nonprofit organization dedicated to improving the lives of individuals impacted by LGS through advancing research, awareness, education, and family support. For more information, please visit www.lgsfoundation.org. About SympazanSYMPAZAN is the first and only FDA-approved oral film formulation of clobazam, a benzodiazepine approved for adjunctive t...